Cardinal Health, Inc. (NYSE: CAH) kicked off on Tuesday, up 0.13% from the previous trading day, before settling in for the closing price of $107.03. Over the past 52 weeks, CAH has traded in a range of $77.56-$116.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 8.47%. While this was happening, its average annual earnings per share was recorded 25.97%. With a float of $241.78 million, this company’s outstanding shares have now reached $251.00 million.
Considering the fact that the conglomerate employs 48000 people, you should pay attention to its efficiency factor.
Cardinal Health, Inc. (CAH) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Distribution Industry. The insider ownership of Cardinal Health, Inc. is 0.60%, while institutional ownership is 89.09%. The most recent insider transaction that took place on Nov 27 ’23, was worth 3,895,411. In this transaction CEO, Pharmaceutical Segment of this company sold 36,642 shares at a rate of $106.31, taking the stock ownership to the 35,202 shares. Before that another transaction happened on Aug 28 ’23, when Company’s CEO, Pharmaceutical Segment sold 6,712 for $89.81, making the entire transaction worth $602,805. This insider now owns 44,202 shares in total.
Cardinal Health, Inc. (CAH) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 25.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.27% during the next five years compared to 4.23% growth over the previous five years of trading.
Cardinal Health, Inc. (NYSE: CAH) Trading Performance Indicators
Take a look at Cardinal Health, Inc.’s (CAH) current performance indicators. Last quarter, stock had a quick ratio of 0.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.12. Likewise, its price to free cash flow for the trailing twelve months is 7.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.54, a number that is poised to hit 1.96 in the next quarter and is forecasted to reach 7.98 in one year’s time.
Technical Analysis of Cardinal Health, Inc. (CAH)
Compared to the last year’s volume of 2.26 million, its volume of 1.49 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 20.91%. Additionally, its Average True Range was 1.97.
During the past 100 days, Cardinal Health, Inc.’s (CAH) raw stochastic average was set at 49.89%, which indicates a significant increase from 29.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.15% in the past 14 days, which was lower than the 20.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $109.28, while its 200-day Moving Average is $99.64. Nevertheless, the first resistance level for the watch stands at $107.82 in the near term. At $108.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $108.94. If the price goes on to break the first support level at $106.71, it is likely to go to the next support level at $106.24. Now, if the price goes above the second support level, the third support stands at $105.59.
Cardinal Health, Inc. (NYSE: CAH) Key Stats
The company with the Market Capitalisation of 26.07 billion has total of 243,233K Shares Outstanding. Its annual sales at the moment are 205,012 M in contrast with the sum of 261,000 K annual income. Company’s last quarter sales were recorded 57,445 M and last quarter income was 353,000 K.
